Optimizing Early Infant HIV Diagnosis through the

alexa-scheidler
Published  · 16 slides · 0 views
↓ Download
Optimizing Early Infant HIV Diagnosis through the
1 / 1
Optimizing Early Infant HIV Diagnosis through the - slide 1 of 16 Optimizing Early Infant HIV Diagnosis through the - slide 2 of 16 Optimizing Early Infant HIV Diagnosis through the - slide 3 of 16 Optimizing Early Infant HIV Diagnosis through the - slide 4 of 16 Optimizing Early Infant HIV Diagnosis through the - slide 5 of 16 Optimizing Early Infant HIV Diagnosis through the - slide 6 of 16 Optimizing Early Infant HIV Diagnosis through the - slide 7 of 16 Optimizing Early Infant HIV Diagnosis through the - slide 8 of 16 Optimizing Early Infant HIV Diagnosis through the - slide 9 of 16 Optimizing Early Infant HIV Diagnosis through the - slide 10 of 16 Optimizing Early Infant HIV Diagnosis through the - slide 11 of 16 Optimizing Early Infant HIV Diagnosis through the - slide 12 of 16 Optimizing Early Infant HIV Diagnosis through the - slide 13 of 16 Optimizing Early Infant HIV Diagnosis through the - slide 14 of 16 Optimizing Early Infant HIV Diagnosis through the - slide 15 of 16 Optimizing Early Infant HIV Diagnosis through the - slide 16 of 16
Description
Optimizing Early Infant HIV Diagnosis through the Introduction of Point of Care Testing Post-Market Surveillance Case Study Lesotho, October 2017 Post Market surveillance Post-marketing surveillance (PMS) (also post market surveillance) is

Related Topics

Download this presentation From Below

"Optimizing Early Infant HIV Diagnosis through the" is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Presentation Transcript

01
Optimizing Early Infant HIV Diagnosis through the Introduction of Point of Care Testing Post-Market Surveillance
Case Study

Lesotho, October 2017<br>
02
Post Market surveillance Post-marketing surveillance (PMS) (also post market surveillance) is the practice of monitoring the safety of a pharmaceutical drug or medical device after it has been released on the market and is an important part of the science of pharmacovigilance.<br>
03
Why ? Devices offer opportunities for improved diagnosis and management of disease, they also can carry substantial risks.

Gvt & Regulatory bodies need to balance the goals of expanding therapeutic options with safeguarding public health

In recognition of the importance of medical devices, the WHO established a Medical Device Unit
focus research and policy on prioritizing access to medical devices in low-resource settings
Dissemination of innovations, and
Training of biomedical personnel to support the use of devices worldwide<br>